sevrage

Sevrage is a term used in French that translates roughly as withdrawal or weaning. In medical and veterinary contexts it refers to two related but distinct processes: the gradual severing of dependence on a substance or therapy, and the period of withdrawal symptoms that may follow cessation.

In weaning, the goal is to replace a dependency with alternative nutrition or routines, allowing an individual or animal to become independent. In humans, weaning from breast milk or from a particular medication can be gradual, supervised by caregivers or clinicians. In animals, weaning typically involves introducing solid food and ceasing nursing at a species-appropriate age.

Withdrawal, or cessation sevrage, describes the physical and psychological symptoms that arise after stopping a drug, medication, or addictive behavior. Severity and duration depend on the substance, dosage, duration of use, and individual factors. Common examples include opioids, alcohol, benzodiazepines, caffeine, and nicotine. Tapering the dose, substitution therapy, and supportive care reduce risks during withdrawal.

Neonatal withdrawal, or neonatal abstinence syndrome, occurs in newborns exposed to certain substances in utero, most often opioids. Symptoms typically appear within 24 to 72 hours after birth and may include irritability, poor feeding, tremors, vomiting, sweating, and sleep disturbances. Management varies from supportive care to pharmacologic treatment in specialized settings.

Across contexts, sevrage is managed with careful assessment, gradual strategies, and ongoing monitoring to minimize harm and support recovery or development. Education and counseling are often important components for long-term outcomes.